Related Experiment Video

Updated: Apr 6, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.8K

DIGRE: Drug-Induced Genomic Residual Effect Model for Successful Prediction of Multidrug Effects

J Yang1, H Tang1, Y Li2

  • 1Department of Clinical Sciences, Quantitative Biomedical Research Center, University of Texas Southwestern Medical Center Dallas, Texas, USA.

CPT: Pharmacometrics & Systems Pharmacology
|July 31, 2015
PubMed

Insights

A new computational model, the Drug-Induced Genomic Residual Effect (DIGRE) model, accurately predicts how drug combinations affect cells. This tool aids in discovering effective multidrug therapies for complex diseases like cancer.

Area of Science:

  • Computational biology
  • Genomics
  • Pharmacology

Background:

  • Multidrug regimens offer improved efficacy and reduced side effects for complex diseases.
  • Understanding drug interactions is crucial but challenging for multidrug therapies.

Purpose of the Study:

  • To present a novel computational approach, the Drug-Induced Genomic Residual Effect (DIGRE) Computational Model.
  • To predict drug combination effects by modeling drug response and gene expression changes.

Main Methods:

  • Developed the DIGRE Computational Model.
  • Modeled drug response curves and gene expression changes post-treatment.
  • Validated predictions using B-lymphoma and breast cancer cell line datasets.

Main Results:

  • DIGRE model predictions showed significant correlation with experimental results in both tested datasets.
  • The model accurately predicted drug combination effects in OCI-LY3 and MCF cell lines.
  • Demonstrated utility in predicting synergistic or antagonistic drug interactions.

Conclusions:

  • The DIGRE Computational Model is a valuable tool for predicting drug combination effects.
  • This approach can accelerate the discovery of novel and effective multidrug therapies.
  • Facilitates understanding of drug-induced genomic alterations for personalized medicine.

More Related Videos

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data07:17

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

967
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
69
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
117
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
125
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
114
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
152
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
171